Replies to post #34 on Cumberland Pharmaceuticals, Inc. (CPIX)

[surf1944]

Cumberland Pharmaceuticals, Inc. (CPIX)
Sector Healthcare
Industry Drug Manufacturers - Other
Market Cap $118.13M
Beta -

CPIX stock chart

Key Metrics
Current Ratio 12.09
Quick Ratio 11.07
5-Year Projected Earnings Per Share Growth Rate 30.00%
Short Interest 12.29%

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. The company's principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

http://seekingalpha.com/article/862971-5-highly-liquid-healthcare-stocks-with-growth-on-the-horizon?source=yahoo